Clinical trials sponsored by Peking University First Hospital
24
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 2Phase 2 2Not applicable 22
Conditions studied
Recruiting trials led by Peking University First Hospital
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- 68Ga-P3 PET/CT Imaging in Prostate
- 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
- 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
- Adjuvant Chemotherapy for High Malignant Prostate Cancer
- China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
- Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
- Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
- Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors
- Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
- Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
- Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
- Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
- Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis
- Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
- Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
- Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
- Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
- Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy
- Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions
- Prospective Multicenter Registry Study of Multiple System Atrophy in China
- The Development and Validation of MRI-AI-based Predictive Models for csPCa
- The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery
- hUC-MSC-Exosomes for T2DM - Safety & Efficacy
Common questions
How many trials is Peking University First Hospital recruiting for?
Peking University First Hospital is the lead sponsor of 24 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.